Content Creation to Build Local Capacity in Addressing Violent Extremism and Promoting Positive Decision Making Among Malaysian Youth
The Public Affairs Section at the U.S. Embassy Kuala Lumpur will help select the Malaysian partner institution and vet participants in the content production training. The U.S. Embassy Kuala Lumpur will be closely involved in the grant administration.
The Embassy is seeking an organization with experience in creating CVE-focused programs and content in Malaysia to produce documentaries, podcasts, and social media posts effective in countering violent extremism. A successful proposal will integrate the training of a diverse collection of young, local talent to produce their own content effective in supporting CVE efforts.
Specific Objectives:
1. Production of at least three documentaries (video, radio and/or online) focused on contemporary domestic/regional issues related to extremism in Malaysia.
2. The project should provide for the training of a diverse collection of Malaysian content designers, representing several backgrounds, to produce effective CVE-focused content.
3. The proposal should include a plan to publicize the content throughout the country in a wide variety of distribution channels including:
a. National/regional media
b. Radio shows
c. Radio
d. Online
Funding Agency: U.S. Mission to Malaysia
Deadline: September 26, 2019
Amount: $250,000
For more information: Go to grants.gov and search opportunity # SMY-300-FY19-CVE-CONTENT-CREATION
Stewardship Science Academic Alliances (SSAA) Program
The Stewardship Science Academic Alliances (SSAA) Program was established in 2002 to support state-of-the-art research at U.S. academic institutions in areas of fundamental physical science and technology of relevance to the SSP mission. The SSAA Program provides the research experience necessary to maintain a cadre of trained scientists at U.S. universities to meet the nation’s current and future SSP needs, with a focus on those areas not supported by other federal agencies. It supports the DOE/NNSA’s priorities both to address the workforce specific needs in science, technology, engineering, and mathematics and to support the next generation of professionals who will meet those needs.
Funding Agency: NNSA
Deadline: October 29, 2019
Amount: $10,000
For more information: Go to grants.gov and search for opportunity # DE-FOA-0002149
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the nervous system contribution to cancer. Leveraging the knowledge, tools, experimental models and reagents in neuroscience research to uncover novel mechanisms used by the nervous system to promote tumor initiation, progression and metastasis can ultimately inform key areas of cancer research including the prevention and treatment of non-central nervous system tumors.
Funding Agency: NIH
Deadline: May 27, 2022
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-353.html
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages collaborative, transdisciplinary research with both neuroscience and cancer elements, which together will advance current understanding of the nervous system contribution to cancer. Leveraging the knowledge, tools, experimental models and reagents in neuroscience research to uncover novel mechanisms used by the nervous system to promote tumor initiation, progression and metastasis can ultimately inform key areas of cancer research including the prevention and treatment of non-central nervous system tumors.
Funding Agency: NIH
Deadline: May 27, 2022
Amount: $200,000
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-354.html
NCI Clinical and Translational Exploratory/Development Studies (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies–including the use of new clinically-relevant models and imaging technologies–which could lead to first-in-human clinical trials. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk, but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (pre-clinical or clinical).
Funding Agency: NIH
Deadline: July 20, 2022
Amount: $200,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-356.html
National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC)
The 2017 CDC STD Surveillance Report documented continued steep and sustained increases in the three reportable STDs – gonorrhea, chlamydia and syphilis. Congenital syphilis rates reached a 20-year high in 2017. Healthcare providers and health systems remain at the forefront of the battle against STDs. Provider education, technical assistance, and clinical capacity building are critical pieces for a foundation of comprehensive STD clinical prevention in healthcare settings. A dynamic and complex healthcare landscape demands innovative methods to reach both clinicians and healthcare settings from a variety of sectors throughout the U.S in order to meet the goal of optimal STD clinical prevention implementation in the clinical care setting. The purpose of this NOFO is to support The National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC). This network is charged with improving the capacity of healthcare professionals, clinical sites and healthcare systems to employ state-of-the-art knowledge to diagnose, manage, treat and counsel individuals with and at-risk for STDs in order to reduce STD morbidity and improve sexual health on an individual, local and national level. This NOFO supports the following broad strategies : Component A Regional Centers: A1 (Core) – assess training needs and service gaps to inform the development and delivery of comprehensive STD clinical prevention T/TA for providers serving priority populations; A2 (Focus Activity) – provide support to providers and clinical settings to integrate HIV preventive services in STD specialty clinics; A3 (Focus Activity) – support the fellow training program. Component B National STD PTC Coordination Center [NPTC3]; B1 (Core) will facilitate coordination of the NNPTC, collect data to inform training strategies, manage a clinical consultation line and promote the NNPTC; B2 (NPTC3 Focus Activity) – coordinate support for PTCs participating in Focus Activity A1; Component C National STD Curriculum Center [NSTDC]; C1 (Core) – develop an online STD curriculum, develop and facilitate national learning communities and work with regional PTCs to scale up ECHO and other distance learning approaches; C2 (NSTDC Focus Activity) – develop resources, curricula and learning communities specifically to support the increase of HIV preventive services in STD specialty clinics.
Funding Agency: CDC – NCHHSTP
Deadline: November 12, 2019
Amount: $50,000,000
For more information: Go to grants.gov and search for opportunity # CDC-RFA-PS20-2004
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider’s recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Funding Agency: NIH
Deadline: September 7, 2022
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-360.html
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.
Funding Agency: NIH
Deadline: September 7, 2022
Amount: $200,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-355.html
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for intervention research designed to support caregivers of adult cancer patients. Interventions supported by this FOA are intended to provide caregivers with care training, promote coping skills, and ultimately help them manage care. Outcomes of such interventions are expected to (1) optimize patient health care utilization, (2) improve caregiver well-being, and (3) improve patient physical health and psychosocial outcomes.
Funding Agency: NIH
Deadline: September 7, 2022
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-352.html
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are: 1) to improve SCLC therapeutics, focusing on understanding how the molecular vulnerabilities of this cancer could be used to develop targeted agent combinations; and/or, 2) to gain a better understanding of the rapid development of clinical resistance to drug and radiation therapy. This FOA focuses on two of the five research priorities identified in the National Cancer Institute’s 2014 Scientific Framework for Small Cell Lung Cancer (SCLC). Additional priorities of the Framework are stated in this FOA, as studies are expected to use or develop state-of-the-art research tools and omic profiles to identify therapeutic strategies that are relevant to human SCLC disease progression and resistance. The research supported by this FOA will be performed by individual research teams who are expected to collaborate with one another and with a central SCLC Coordinating Center. A third component of the SCLC Consortium focuses on prevention and early detection of SCLC.
Funding Agency: NIH
Deadline: March 11, 2022
Amount: $450,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-361.html
Multisite Clinical Center Common Fund Acute to Chronic Pan Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial optional)
The purpose of this FOA is to support a Multisite Clinical Center to implement the enrollment and multimodal longitudinal assessment of a large cohort of patients that EITHER experienced an acute musculoskeletal trauma OR an acute peri-operative pain event to identify a biosignature for resilience to and/or the transition from acute to chronic pain.
Funding Agency: NIH
Deadline: November 26, 2019
Amount: $3,400,000
For more information: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-013.html
FY 2020 Study of the U.S. Institutes for Scholars
The Study of the U. S. Branch (ECA/A/E/USS), Office of Academic Exchange Programs, Bureau of Educational and Cultural Affairs (ECA), invites proposal submissions from accredited U.S. post-secondary education institutions (community colleges, liberal arts colleges, public and private universities) and other U.S. public and private non-profit organizations meeting the provisions described in Internal Revenue Code section 26 USC 501(c)(3) (see section C. Eligibility Information) to design and implement two (2) Study of the U.S. Institutes (SUSIs) for Scholars, pending the availability of FY 2020 funds.
Each Study of the U.S. Institute will be six weeks in duration, including an approximately four-week academic residency at an academic institution and up to two weeks of an integrated educational study tour. The academic residency should take place on a U.S. university or college campus and should include academic coursework, diverse speakers, time for personal research, and opportunities for interaction with American peers. The study tour should take scholars to another region of the United States and it should complement the academic residency. The programs should conclude in Washington, DC with a minimum stay of two days.
The Institutes should be designed for groups of 18 foreign university-level faculty or professionals, focusing on the themes of 1) Religious Freedom and Pluralism and 2) U.S. Economics and Business. For additional details, please see the full announcement.
Funding Agency: Bureau of Educational and Cultural Affairs
Deadline: October 28, 2019
Amount: $875,000
For more information: https://eca.state.gov/organizational-funding/open-grant-solicitations
Linking the Provide Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider’s recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Funding Agency: NIH
Deadline: September 7, 2022
Amount: $200,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-358.html
Linking the Provide Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider’s recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Funding Agency: NIH
Deadline: July 16, 2022
Amount: $50,000
For more information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-359.html